These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 11064931)
1. [Apolipoprotein E4 and memory decline in the elderly]. Jonker C; Dik MG; van Kamp GJ; Deeg DJ Tijdschr Gerontol Geriatr; 2000 Oct; 31(5):198-202. PubMed ID: 11064931 [TBL] [Abstract][Full Text] [Related]
2. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment. Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169 [TBL] [Abstract][Full Text] [Related]
3. APOE-epsilon4 is associated with memory decline in cognitively impaired elderly. Dik MG; Jonker C; Bouter LM; Geerlings MI; van Kamp GJ; Deeg DJ Neurology; 2000 Apr; 54(7):1492-7. PubMed ID: 10751265 [TBL] [Abstract][Full Text] [Related]
4. Association between apolipoprotein E4 and cognitive decline in elderly adults. Packard CJ; Westendorp RG; Stott DJ; Caslake MJ; Murray HM; Shepherd J; Blauw GJ; Murphy MB; Bollen EL; Buckley BM; Cobbe SM; Ford I; Gaw A; Hyland M; Jukema JW; Kamper AM; Macfarlane PW; Jolles J; Perry IJ; Sweeney BJ; Twomey C; J Am Geriatr Soc; 2007 Nov; 55(11):1777-85. PubMed ID: 17979899 [TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E epsilon4 and change in cognitive functioning in community-dwelling older adults. Swan GE; Lessov-Schlaggar CN; Carmelli D; Schellenberg GD; La Rue A J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):196-201. PubMed ID: 16306239 [TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E epsilon4 allele and lorazepam effects on memory in high-functioning older adults. Pomara N; Willoughby L; Wesnes K; Greenblatt DJ; Sidtis JJ Arch Gen Psychiatry; 2005 Feb; 62(2):209-16. PubMed ID: 15699298 [TBL] [Abstract][Full Text] [Related]
7. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers. Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495 [TBL] [Abstract][Full Text] [Related]
8. Impact of APOE status on cognitive maintenance in healthy elderly persons. Zehnder AE; Bläsi S; Berres M; Monsch AU; Stähelin HB; Spiegel R Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849 [TBL] [Abstract][Full Text] [Related]
9. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment. Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270 [TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E, cardiovascular disease and cognitive function in aging women. Kang JH; Logroscino G; De Vivo I; Hunter D; Grodstein F Neurobiol Aging; 2005 Apr; 26(4):475-84. PubMed ID: 15653176 [TBL] [Abstract][Full Text] [Related]
11. Do apolipoprotein E genotype and educational attainment predict the rate of cognitive decline in normal aging? A 12-year follow-up of the Maastricht Aging Study. Van Gerven PW; Van Boxtel MP; Ausems EE; Bekers O; Jolles J Neuropsychology; 2012 Jul; 26(4):459-72. PubMed ID: 22642392 [TBL] [Abstract][Full Text] [Related]
12. Plasma levels of apolipoprotein E and cognitive function in old age. Mooijaart SP; van Vliet P; van Heemst D; Rensen PC; Berbée JF; Jolles J; de Craen AJ; Westendorp RG Ann N Y Acad Sci; 2007 Apr; 1100():148-61. PubMed ID: 17460173 [TBL] [Abstract][Full Text] [Related]
13. Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly. Dik MG; Jonker C; Comijs HC; Bouter LM; Twisk JW; van Kamp GJ; Deeg DJ Neurology; 2001 Dec; 57(12):2217-22. PubMed ID: 11756600 [TBL] [Abstract][Full Text] [Related]
14. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study. Knopman DS; Mosley TH; Catellier DJ; Coker LH; Alzheimers Dement; 2009 May; 5(3):207-14. PubMed ID: 19362884 [TBL] [Abstract][Full Text] [Related]
15. Neuropsychological measures in normal individuals that predict subsequent cognitive decline. Blacker D; Lee H; Muzikansky A; Martin EC; Tanzi R; McArdle JJ; Moss M; Albert M Arch Neurol; 2007 Jun; 64(6):862-71. PubMed ID: 17562935 [TBL] [Abstract][Full Text] [Related]
16. The effect of the ApoE genotype on the association between head circumference and cognition. Kim KR; Lee KS; Kim EA; Cheong HK; Oh BH; Hong CH Am J Geriatr Psychiatry; 2008 Oct; 16(10):819-25. PubMed ID: 18827228 [TBL] [Abstract][Full Text] [Related]
17. Patterns of subjective memory impairment in the elderly: association with memory performance. Jessen F; Wiese B; Cvetanovska G; Fuchs A; Kaduszkiewicz H; Kölsch H; Luck T; Mösch E; Pentzek M; Riedel-Heller SG; Werle J; Weyerer S; Zimmermann T; Maier W; Bickel H Psychol Med; 2007 Dec; 37(12):1753-62. PubMed ID: 17623488 [TBL] [Abstract][Full Text] [Related]
18. APOE genotype modulates the effect of serum calcium levels on cognitive function in old age. van Vliet P; Oleksik AM; Mooijaart SP; de Craen AJ; Westendorp RG Neurology; 2009 Mar; 72(9):821-8. PubMed ID: 19255409 [TBL] [Abstract][Full Text] [Related]
19. No association between subjective memory complaints and apolipoprotein E genotype in cognitively intact elderly. Harwood DG; Barker WW; Ownby RL; Mullan M; Duara R Int J Geriatr Psychiatry; 2004 Dec; 19(12):1131-9. PubMed ID: 15526312 [TBL] [Abstract][Full Text] [Related]
20. The relation between APOE status and neuropsychological memory test performance: an analysis of the Canadian Study of Health and Aging. Klages J; Fisk JD Brain Cogn; 2002 Jul; 49(2):201-4. PubMed ID: 15259389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]